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342 Abstractsaffected by ulceration. Despite the existence of numerous studies
favouring angiosome-targeted revascularization the concept re-
mains controversial. The aim of our study was to compare the
main treatment strategies in CLI with tissue lesion, surgical and
endovascular revascularization, using angiosome concept in terms
of the wound healing and freedom from major amputation.
Methods: The study cohort comprises a total of 975 consecutive
patients who underwent endovascular or surgical revascularization
in below the knee arteries between January 2010eJuly 2013. Data
collection was performed by reviewing patient’s records from our
prospectively collected database as well as patient’s angiograms
and MRIs. Statistical analysis was performed using a SPSS statistical
software (SPSS v. 22.0, SPSS Inc., Chicago, Ill., USA). Differences
between bypass surgery and PTA groups were adjusted by esti-
mating a propensity score, which was employed for one-to-one
matching as well as adjust for other variables in estimating their
impact on the postoperative outcome.
Results: Propensity score matching with a calliper width of 0.02
resulted in 252 pairs with similar baseline and operative charac-
teristics. Actuarial analysis showed the positive impact of angio-
some targeted bypass surgery on wound healing (p ¼ 0.046, HR
1.295, 95%CI 1.005e1.668) compared with angiosome targeted
angioplasty. Interestingly also non-angiosome targeted bypass
surgery achieved better wound healing rates than PTA indepen-
dently of the angiosome oriented strategy (p ¼ 0.001, HR 1.890,
95%CI 1.292e2.766). Cox proportional hazards analysis showed
that angiosome targeted revascularization (p ¼ 0.036, HR 1.294,
95%CI 1.017e1.647), bypass surgery (p < 0.0001, HR 1.791, 95%CI
1.412e2.272), C-reactive protein 10 mg/dL (p ¼ 0.005, HR 1.416,
95%CI 1.110e1.806) and the number of affected angiosomes (p ¼
0.024, HR 0.854, 95%CI 0.744e0.979) were independent pre-
dictors of wound healing (Fig. 1).The non-angiosome targeted
angioplasty was associated with the highest risk of major ampu-
tation as compared with non-angiosome targeted bypass surgery
(p ¼ 0.049, HR 0.569, 95%CI 0.325e0.997), angiosome targeted
bypass surgery (p ¼ 0.033, HR 0.589, 95%CI 0.362e0.958) and
angiosome targeted angioplasty (p ¼ 0.005, HR 0.556, 95%CI
0.371e0.834).
Conclusion: The healing of ulcer in patients with CLI is signiﬁcantly
better in bypass surgery independent of the angiosome concept
rather than angiosome-targeted percutaneous transluminal an-
gioplasty. Furthermore low C-reactive protein and low number of
affected angiosomes plays important role in both wound healing
and the risk for major amputation.A New Carotid 3D MRI Sequence for Stenosis Measurement and
Plaque Characterization at the Same Time
A. Millon, S. Bros, L. Boussel, P.M. Robson, Z. Fayad, M. Sigovan,
P. Douek
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Introduction: Risk of stroke related to carotid atherosclerosis de-
pends on degree of stenosis and carotid plaque vulnerability. We
propose a new 3D MRI sequence (3D-T1) allowing measurement of
these parameters at the same time without gadolinium injection.
Methods: Forty-six patients with atherosclerotic plaque of carotid
bifurcation underwent the new 3D-T1 sequence (4 minutes
acquisition time), and the standard protocol comprising
Gadolinium-enhanced MR Angiography (CE-MRA) for stenosis
measurement and 2D HR-MRI sequences for plaque characteriza-
tion on a 3T MRI scanner. Qualitative evaluation was performed bytwo observers on both the 3D-T1 and the whole standard protocol
with the following parameters: overall image quality and plaque
components evaluation (intraplaque hemorrhage IPH, lipid core,
calciﬁcations, ulceration and ﬁbrous cap rupture). Furthermore,
the NASCET degree of stenosis was calculated on 3D-T1 and CE-
MRA. Comparison between 3D-T1 and the standard protocol
were performed using ManneWhitney U tests and Pearson co-
efﬁcients of correlation. Inter-observer agreements were assessed
by Kappa. Among these patients, 18 underwent carotid endar-
terectomy. Histological examination was performed. Sensitivity
and speciﬁcity of the 2 protocols for diagnosis of vulnerable plaque
features were calculated. Correlation between histological and
MRI results were assessed using Spearman’s rank correlation test.
Results: Four patients were excluded due to artifacts on the
standard protocol and one on the 3D-T1. 3D-T1 showed a better
image quality in comparison with the standard protocol (3.59 
1.02 vs. 3.27  1.01; p < 0.05). For the stenosis degree, correla-
tion between 3D-T1 and CE-MRA was excellent (R ¼ 0.93) despite
a trend for T1-3D to overestimate it (8.9%; IC: 11.95 to 29.82).
Interobserver variability showed a good agreement between ob-
servers (kappa >0.87). Sensibility and speciﬁcity for IPH diagnosis
was 50% and 100% for the standard protocol and 100% and 83%
for the 3D-T1 sequence. Sensibility and speciﬁcity were similar
between 3D and 2D sequences for diagnosis of the others plaque
features. Histological correlation was better with 3D-T1 than with
standard protocol for IPH (0.87 vs. 0.57) (Fig.). There was no dif-
ference for lipid core and calciﬁcation (0.66 and 0.88). For ulcer-
ation and cap rupture, correlation was slightly better with the
standard protocol (0.86 vs. 0.72).
Conclusion: The 3D-T1 sequence without gadolinium injection al-
lows a reproducible measure of carotid stenosis in comparison of
CE-MRA with a slight overestimation. The 3D-T1 sequence also
allows a reliable and faster carotid atherosclerotic plaque charac-
terization, in comparison with the reference protocol with an
improvement of IPH diagnosis.Urgent Carotid Artery Stenting Does Not Increase the Risk for
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Introduction: Current ESVS guidelines recommend that patients
with a signiﬁcant symptomatic stenosis should be operated within
14 days of onset of symptoms. However, recent reports indicate
that carotid endarterectomy (CEA) within 2 days after a neurologic
event may be associated with a higher peri-procedural risk of
stroke. If urgent carotid artery stenting (CAS) carries a similar high
risk is unclear.
The aim of this study was to analyse whether urgent CAS after a
neurologic event increases the peri-procedural risks.
Methods: Retrospective analysis of all CAS registered in a validated
nationwide registry between January 1st, 2005 and June 7th, 2013.
Only symptomatic patients treated with CAS for a stenosis of the
internal carotid artery were included. The rates of stroke and acute
myocardial infarctions (AMI) were recorded at 30 days. Mortality
data were collected from the national death registry.
Patients were categorized according to time from index event
until surgery; 0e2 days, 3e7 days, 8e14 days, and 15e180 days.
A secondary analysis was performed for 0e7 days, 8e14 days,
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combined stroke and death rate.
Results: In total 269 patients had complete data and were included
in the analysis.The demographic and clinical data were similar in the
groups The 30-day combined stroke and death rate did not differ
signiﬁcantly between the groups; 0% (0/12) in the group treated 0e
2 days, versus 3.9% (3/76), 2.9% (2/68), and 5.3% (6/113) for the
patients treated at 3e7 days, 8e14 days and 15e180 days
respectively (p ¼ 0.759). The 30-day stroke and death rate in the
secondary analysis were also similar between groups; 3.4% (3/88),
2.9% (2/68), 6.3% (3/48), and 4.6% (3/65) respectively, (p¼ 0.813).
Conclusion: In this national registry study, limited by small
numbers, patients that underwent urgent CAS after onset of a
neurologic event had no additional risk of suffering from a peri-
operative complication.Lessons from 500 Adverse Event Reports on SFA Stents from
MAUDE Database-need for Action by ESVS?
R. Gambhir
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Introduction: When a Boeing aircraft develops a problem at New
York, within the next 24 hrs the whole Boeing ﬂeet, the world over,
gets an alert with initial defect report, cause and a ﬁx. On the
other hand when the trigger mechanism of delivery system of an
SFA stent fails in a London Hospital, nothing similar happens. FDA
mandates the manufacturers to report all adverse events within 30
days on the MUADE database. An analysis of 500 adverse event
reports on SFA stents reveals lessons for the vascular societies and
calls for uniﬁed action for the sake of patient safety.
Methods: MAUDE database was searched for all adverse event
reports on SFA stents from 01/04/2012 to 31/03/2014. Each report
lists the event description, the date, patient injury, intervention if
required and the manufacturer’s narrative.
Results: 500 SFA stent adverse reports were recorded and ana-
lysed. All known manufacturers were listed. Adverse reports from
2 stent manufacturers were signiﬁcantly more than the others. A
similar deployment failure was reported for over 1 year by one
manufacturer. More than 1/3rd of the reported cases had either a
failure in deployment of the stent or retrieval of the standard
delivery system (sds). In another 1/3rd the stent was damaged
after deployment-twisted, torqued, fractured, or occluded. In the
remaining 1/3rd there were multitudes of problems from breakage
of sds components and their retention within the patient to
dislodgment.
Adverse patient effects included Acute Limb ischemia, limb loss
and death. Majority required endovascular intervention, failing
which an open procedure was performed in 20% of patients.
Analysis of manufacturer’s narrative rarely revealed no attrib-
utable cause, the malfunction, mal-deployment was labeled as
procedure related and not device related. The manufacturer’s
narrative often stated that the device met pre-release speciﬁca-
tions and no manufacturing defect could be identiﬁed.
Conclusion: A review of adverse event reports form manufac-
turer’s clearly indicates that the adverse event was procedure
related and probably due to the operator not exercising due care
or not following the IFU. There is a need for the societies to take
a lead in user adverse event reporting, analysis and communi-
cating these to the centre’s on a deﬁnitive time scale in a more
open and uniﬁed manner to prevent patient harm and improve
outcomes.Impact of Early Pelvic and Lower Limbs Reperfusion and
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Introduction: Spinal cord ischemia (SCI) is a devastating compli-
cation following thoracoabdominal aortic aneurysm (TAAA)
endovascular repair. In an attempt to reduce its occurrence, we
have modiﬁed our implantation protocol in January 2010 by
withdrawing all large sheaths from the iliac arteries as soon as
possible during the procedure. In addition, we have also modiﬁed
our perioperative protocol (aggressive blood and platelet trans-
fusion, median arterial pressure monitoring >80 mmHg, and sys-
tematic cerebrospinal ﬂuid drainage except for type 4 TAAA).
Methods: Between October 2004 and December 2013, we have
performed 204 TAAA endovascular repairs with custom made
devices manufactured with branches and fenestrations to perfuse
the visceral vessels. Data from all patients were prospectively
collected in an electronic database. We compared the early out-
comes of patients treated before (group 1, 43 patients) and after
(group 2, 161 patients) modiﬁcation of our implantation and
perioperative protocols.
Results: Group 1 and 2 patients had similar comorbidities (median
age at repair 70.9 years [65.2e77]), aneurysm characteristics
(median diameter 58.5 mm [53e65]), and length of procedure
(median 190 min [150e240]). The in-hospital mortality rate was
11.6% in group 1 vs. 5.6% in group 2 respectively (RR ¼ 0.481
[0.17e1.36]; p ¼ 0.09). The spinal cord ischemia rate was 14% vs.
1.2% (RR ¼ 1.148 [1.016e1.296]; p ¼ 0.001) respectively. If we
exclude Type 4 TAAA from this analysis, the spinal cord ischemia
rate was 25% (6/24 patients) in group 1 vs. 2.1% (2/95 patients) in
group 2 (RR ¼ 1.306 [1.034e1.648]; p < 0.001) respectively.
Conclusion: Early restoration of arterial ﬂow to the pelvis and
lower limbs and aggressive perioperative management signiﬁ-
cantly reduces SCI following TAAA endovascular repair. With this
modiﬁed approach, extensive TAAA endovascular repairs are
associated with low rates of SCI.Endovascular Management of Rupture in Acute Type B Aortic
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Introduction: Reports of thoracic endovascular aortic repair
(TEVAR) for complicated acute type B dissection bring together a
large range of clinical presentations.With a 50% of 30-day mortality
rate whenmanaged with open surgery, rupture is themost dramatic
complication of acute type B dissections. We investigated the out-
comes of TEVAR for acute type B dissection complicated by rupture
(R-ABD) to assess the results of this particularly critical subgroup.
Methods: A review of consecutive TEVAR for R-ABD in two tertiary
centers was performed using prospectively maintained database.
Results: Between 2000 and 2014, 24 patients (mean age 68 years;
14 males) underwent TEVAR for R-ABD. Sixteen (67%) were in
shock (Systolic blood pressure <80 mmHg) before surgery and 20
required chest drainage for hemothorax. Proximal entry tear was
in zone 2 in 7 (29%) and 3 in 17 (71%). Five patients required
coverage of the left subclavian artery for adequate proximal
